Test Bank - Focus on Nursing Pharmacology 9th Edition by Amy Karch Chapter 1-59
,Test |Bank |- |Focus |on |Nursing |Pharmacology |(9th |Edition |by |Karch) 3
Chapter 01 - Introduction to Drugs
| | | | |
A |nurse |working |in |radiology |administers |iodine |to |a |patient |who |is |having |a |computed |tomography |(CT)
|scan. |The |nurse |working |on |the |oncology |unit |administers |chemotherapy |to |patients |who |have
|cancer. |At |the |Public |Health |Department, |a |nurse |administers |a |measles-mumps-rubella |(MMR)
|vaccine |to |a |14-month-old |child |as |a |routine |immunization. |Which |branch |of |pharmacology |best
|describes |the |actions |of |all |three |nurses?
Pharmacoeconomics
|Pharmacotherapeutics
|Pharmacodynamics
|Pharmacokinetics
| Ans: B
Feedback:
Pharmacology |is |the |study |of |the |biologic |effects |of |chemicals. |Nurses |are |involved |with |clinical
|pharmacology |or |pharmacotherapeutics, |which |is |a |branch |of |pharmacology |that |deals |with |the |uses |of
|drugs |to |treat, |prevent, |and |diagnose |disease. |The |radiology |nurse |is |administering |a |drug |to |help
|diagnose |a |disease. |The |oncology |nurse |is |administering |a |drug |to |help |treat |a |disease.
Pharmacoeconomics |includes |any |costs |involved |in |drug |therapy. |Pharmacodynamics |involves |how |a
|drug |affects |the |body |and |pharmacokinetics |is |how |the |body |acts |on |the |body.
A |physician |has |ordered |intramuscular |(IM) |injections |of |morphine, |a |narcotic, |every |4 |hours |as |needed |for
|pain |in |a |motor |vehicle |accident |victim. |The |nurse |is |aware |this |drug |has |a |high |abuse |potential.
Under |what |category |would |morphine |be |classified?
Schedule |I
|Schedule |II
|Schedule
| III |Schedule
|IV |Ans: B
Feedback:
Narcotics |with |a |high |abuse |potential |are |classified |as |Schedule |II |drugs |because |of |severe |dependence
Want |to |earn |$1.236
Distribution |of |this |document |is extra |per |year?
|illegal
,Test |Bank |- |Focus |on |Nursing |Pharmacology |(9th |Edition |by |Karch) 4
liability. |Schedule |I |drugs |have |high |abuse |potential |and |no |accepted |medical |use. |Schedule |III |drugs
|have |a |lesser |abuse |potential |than |II |and |an |accepted |medical |use. |Schedule |IV |drugs |have |low |abuse
|potential |and |limited |dependence |liability.
When |involved |in |phase |III |drug |evaluation |studies, |what |responsibilities |would |the |nurse |have?
|Working |with |animals |who |are |given |experimental |drugs
Choosing |appropriate |patients |to |be |involved |in |the |drug |study
|Monitoring |and |observing |patients |closely |for |adverse |effects
|Conducting |research |to |determine |effectiveness |of |the |drug |Ans: | C
Feedback:
Phase |III |studies |involve |use |of |a |drug |in |a |vast |clinical |population |in |which |patients |are |asked |to |record
|any |symptoms |they |experience |while |taking |the |drugs. |Nurses |may |be |responsible |for |helping |collect
|and |analyze |the |information |to |be |shared |with |the |Food |and |Drug |Administration |(FDA) |but |would |not
|conduct |research |independently |because |nurses |do |not |prescribe |medications. |Use |of |animals |in |drug
|testing |is |done |in |the |preclinical |trials. |Select |patients |who |are |involved |in |phase |II |studies |to |participate
|in |studies |where |the |participants |have |the |disease |the |drug |is |intended |to |treat. |These |patients |are
|monitored |closely |for |drug |action |and |adverse |effects. |Phase |I |studies |involve |healthy |human |volunteers
|who |are |usually |paid |for |their |participation. |Nurses |may |observe |for |adverse |effects |and |toxicity.
What |concept |is |considered |when |generic |drugs |are |substituted |for |brand |name |drugs?
|Bioavailability
Critical |concentration
|Distribution
Half-life
| Ans: A
Feedback:
Bioavailability |is |the |portion |of |a |dose |of |a |drug |that |reaches |the |systemic |circulation |and |is |available |to
|act |on |body |cells. |Binders |used |in |a |generic |drug |may |not |be |the |same |as |those |used |in |the |brand |name
|drug. |Therefore, |the |way |the |body |breaks |down |and |uses |the |drug |may |differ, |which |may |eliminate |a
|generic |drug |substitution. |Critical |concentration |is |the |amount |of |a |drug |that |is |needed |to |cause |a
|therapeutic |effect |and |should |not |differ |between |generic |and |brand |name |medications. |Distribution |is
|the |phase |of |pharmacokinetics, |which |involves |the |movement |of |a |drug |to |the |body’s |tissues |and |is |the
Want |to |earn |$1.236
Distribution |of |this |document |is extra |per |year?
|illegal
, Test |Bank |- |Focus |on |Nursing |Pharmacology |(9th |Edition |by |Karch) 5
same |in |generic |and |brand |name |drugs. |A |drug’s |half-life |is |the |time |it |takes |for |the |amount |of |drug |to
|decrease |to |half |the |peak |level, |which |should |not |change |when |substituting |a |generic |medication.
A |nurse |is |assessing |the |patient’s |home |medication |use. |After |listening |to |the |patient |list |current |medications,
|the |nurse |asks |what |priority |question?
Do |you |take |any |generic |medications?
Are |any |of |these |medications |orphan |drugs?
Are |these |medications |safe |to |take |during |pregnancy? |Do
| you |take |any |over-the-counter |medications?
Ans: D
Feedback:
It |is |important |for |the |nurse |to |specifically |question |use |of |over-the-counter |medications |because |patients
|may |not |consider |them |important. |The |patient |is |unlikely |to |know |the |meaning |of |orphan |drugs |unless
|they |too |are |health |care |providers. |Safety |during |pregnancy, |use |of |a |generic |medication, |or
|classification |of |orphan |drugs |are |things |the |patient |would |be |unable |to |answer |but |could |be |found |in
|reference |books |if |the |nurse |wishes |to |research |them.
After |completing |a |course |on |pharmacology |for |nurses, |what |will |the |nurse |know?
|Everything |necessary |for |safe |and |effective |medication |administration
Current |pharmacologic |therapy; |the |nurse |will |not |require |ongoing |education |for |5 |years.
|General |drug |information; |the |nurse |can |consult |a |drug |guide |for |specific |drug |information.
|The |drug |actions |that |are |associated |with |each |classification |of |medication |Ans: C
Feedback:
After |completing |a |pharmacology |course |nurses |will |have |general |drug |information |needed |for |safe |and
|effective |medication |administration |but |will |need |to |consult |a |drug |guide |for |specific |drug |information
|before |administering |any |medication. |Pharmacology |is |constantly |changing, |with |new |drugs |entering
| the |market |and |new |uses |for |existing |drugs |identified. |Continuing |education |in |pharmacology |is
|essential |to |safe |practice. |Nurses |tend |to |become |familiar |with |the |medications |they |administer |most
|often, |but |there |will |always |be |a |need |to |research |new |drugs |and |also |those |the |nurse |is |not |familiar |with
|because |no |nurse |knows |all |medications.
Want |to |earn |$1.236
Distribution |of |this |document |is extra |per |year?
|illegal
,Test |Bank |- |Focus |on |Nursing |Pharmacology |(9th |Edition |by |Karch) 3
Chapter 01 - Introduction to Drugs
| | | | |
A |nurse |working |in |radiology |administers |iodine |to |a |patient |who |is |having |a |computed |tomography |(CT)
|scan. |The |nurse |working |on |the |oncology |unit |administers |chemotherapy |to |patients |who |have
|cancer. |At |the |Public |Health |Department, |a |nurse |administers |a |measles-mumps-rubella |(MMR)
|vaccine |to |a |14-month-old |child |as |a |routine |immunization. |Which |branch |of |pharmacology |best
|describes |the |actions |of |all |three |nurses?
Pharmacoeconomics
|Pharmacotherapeutics
|Pharmacodynamics
|Pharmacokinetics
| Ans: B
Feedback:
Pharmacology |is |the |study |of |the |biologic |effects |of |chemicals. |Nurses |are |involved |with |clinical
|pharmacology |or |pharmacotherapeutics, |which |is |a |branch |of |pharmacology |that |deals |with |the |uses |of
|drugs |to |treat, |prevent, |and |diagnose |disease. |The |radiology |nurse |is |administering |a |drug |to |help
|diagnose |a |disease. |The |oncology |nurse |is |administering |a |drug |to |help |treat |a |disease.
Pharmacoeconomics |includes |any |costs |involved |in |drug |therapy. |Pharmacodynamics |involves |how |a
|drug |affects |the |body |and |pharmacokinetics |is |how |the |body |acts |on |the |body.
A |physician |has |ordered |intramuscular |(IM) |injections |of |morphine, |a |narcotic, |every |4 |hours |as |needed |for
|pain |in |a |motor |vehicle |accident |victim. |The |nurse |is |aware |this |drug |has |a |high |abuse |potential.
Under |what |category |would |morphine |be |classified?
Schedule |I
|Schedule |II
|Schedule
| III |Schedule
|IV |Ans: B
Feedback:
Narcotics |with |a |high |abuse |potential |are |classified |as |Schedule |II |drugs |because |of |severe |dependence
Want |to |earn |$1.236
Distribution |of |this |document |is extra |per |year?
|illegal
,Test |Bank |- |Focus |on |Nursing |Pharmacology |(9th |Edition |by |Karch) 4
liability. |Schedule |I |drugs |have |high |abuse |potential |and |no |accepted |medical |use. |Schedule |III |drugs
|have |a |lesser |abuse |potential |than |II |and |an |accepted |medical |use. |Schedule |IV |drugs |have |low |abuse
|potential |and |limited |dependence |liability.
When |involved |in |phase |III |drug |evaluation |studies, |what |responsibilities |would |the |nurse |have?
|Working |with |animals |who |are |given |experimental |drugs
Choosing |appropriate |patients |to |be |involved |in |the |drug |study
|Monitoring |and |observing |patients |closely |for |adverse |effects
|Conducting |research |to |determine |effectiveness |of |the |drug |Ans: | C
Feedback:
Phase |III |studies |involve |use |of |a |drug |in |a |vast |clinical |population |in |which |patients |are |asked |to |record
|any |symptoms |they |experience |while |taking |the |drugs. |Nurses |may |be |responsible |for |helping |collect
|and |analyze |the |information |to |be |shared |with |the |Food |and |Drug |Administration |(FDA) |but |would |not
|conduct |research |independently |because |nurses |do |not |prescribe |medications. |Use |of |animals |in |drug
|testing |is |done |in |the |preclinical |trials. |Select |patients |who |are |involved |in |phase |II |studies |to |participate
|in |studies |where |the |participants |have |the |disease |the |drug |is |intended |to |treat. |These |patients |are
|monitored |closely |for |drug |action |and |adverse |effects. |Phase |I |studies |involve |healthy |human |volunteers
|who |are |usually |paid |for |their |participation. |Nurses |may |observe |for |adverse |effects |and |toxicity.
What |concept |is |considered |when |generic |drugs |are |substituted |for |brand |name |drugs?
|Bioavailability
Critical |concentration
|Distribution
Half-life
| Ans: A
Feedback:
Bioavailability |is |the |portion |of |a |dose |of |a |drug |that |reaches |the |systemic |circulation |and |is |available |to
|act |on |body |cells. |Binders |used |in |a |generic |drug |may |not |be |the |same |as |those |used |in |the |brand |name
|drug. |Therefore, |the |way |the |body |breaks |down |and |uses |the |drug |may |differ, |which |may |eliminate |a
|generic |drug |substitution. |Critical |concentration |is |the |amount |of |a |drug |that |is |needed |to |cause |a
|therapeutic |effect |and |should |not |differ |between |generic |and |brand |name |medications. |Distribution |is
|the |phase |of |pharmacokinetics, |which |involves |the |movement |of |a |drug |to |the |body’s |tissues |and |is |the
Want |to |earn |$1.236
Distribution |of |this |document |is extra |per |year?
|illegal
, Test |Bank |- |Focus |on |Nursing |Pharmacology |(9th |Edition |by |Karch) 5
same |in |generic |and |brand |name |drugs. |A |drug’s |half-life |is |the |time |it |takes |for |the |amount |of |drug |to
|decrease |to |half |the |peak |level, |which |should |not |change |when |substituting |a |generic |medication.
A |nurse |is |assessing |the |patient’s |home |medication |use. |After |listening |to |the |patient |list |current |medications,
|the |nurse |asks |what |priority |question?
Do |you |take |any |generic |medications?
Are |any |of |these |medications |orphan |drugs?
Are |these |medications |safe |to |take |during |pregnancy? |Do
| you |take |any |over-the-counter |medications?
Ans: D
Feedback:
It |is |important |for |the |nurse |to |specifically |question |use |of |over-the-counter |medications |because |patients
|may |not |consider |them |important. |The |patient |is |unlikely |to |know |the |meaning |of |orphan |drugs |unless
|they |too |are |health |care |providers. |Safety |during |pregnancy, |use |of |a |generic |medication, |or
|classification |of |orphan |drugs |are |things |the |patient |would |be |unable |to |answer |but |could |be |found |in
|reference |books |if |the |nurse |wishes |to |research |them.
After |completing |a |course |on |pharmacology |for |nurses, |what |will |the |nurse |know?
|Everything |necessary |for |safe |and |effective |medication |administration
Current |pharmacologic |therapy; |the |nurse |will |not |require |ongoing |education |for |5 |years.
|General |drug |information; |the |nurse |can |consult |a |drug |guide |for |specific |drug |information.
|The |drug |actions |that |are |associated |with |each |classification |of |medication |Ans: C
Feedback:
After |completing |a |pharmacology |course |nurses |will |have |general |drug |information |needed |for |safe |and
|effective |medication |administration |but |will |need |to |consult |a |drug |guide |for |specific |drug |information
|before |administering |any |medication. |Pharmacology |is |constantly |changing, |with |new |drugs |entering
| the |market |and |new |uses |for |existing |drugs |identified. |Continuing |education |in |pharmacology |is
|essential |to |safe |practice. |Nurses |tend |to |become |familiar |with |the |medications |they |administer |most
|often, |but |there |will |always |be |a |need |to |research |new |drugs |and |also |those |the |nurse |is |not |familiar |with
|because |no |nurse |knows |all |medications.
Want |to |earn |$1.236
Distribution |of |this |document |is extra |per |year?
|illegal
